Neuproscan screenshot

Neuproscan

HealthcareFree

Identify Alzheimer's years ahead using NeuProScan's advanced AI platform

Last updated Aug 8, 2024

Claim Tool

What is Neuproscan?

NeuProScan is a versatile AI platform designed to predict the likelihood of developing Alzheimer's disease years in advance by analyzing a single MRI scan. This tool is beneficial for both individual doctors and large hospitals, as it can be used on-device or in the cloud and supports the creation of custom AI models. The platform stands out for its accuracy and efficiency, selecting only the most impactful MRI slices for analysis, thereby improving diagnostic precision and optimizing costly PET scan utilization.

Neuproscan's Top Features

Key capabilities that make Neuproscan stand out.

AI-driven predictions

Single MRI scan analysis

Customizable AI models

On-device and cloud operations

Impactful MRI slice selection

High diagnostic accuracy

Supports research purposes

Beneficial for doctors and hospitals

Optimizes costly PET scans

User-friendly interface

Use Cases

Who benefits most from this tool.

Doctors

Improving diagnostic accuracy for early Alzheimer’s by selecting impactful MRI slices.

Hospitals

Optimizing the use of costly PET scans and enhancing patient care with accurate predictions.

Researchers

Using an advanced AI tool for conducting Alzheimer's disease research.

Patients and families

Planning for the future by getting early predictions of Alzheimer’s likelihood.

Clinical Trial Managers

Identifying eligible patients earlier for participation in clinical trials.

Healthcare Administrators

Managing resources effectively by reducing the demand on expensive diagnostic procedures.

Tech-Savvy Doctors

Creating custom AI models tailored to specific diagnostic needs.

Public Health Officials

Monitoring and planning for Alzheimer's disease trends on a larger scale.

Medical Educators

Training new doctors on advanced diagnostic tools and early detection methods.

Medical Device Manufacturers

Incorporating advanced AI predictions into next-gen MRI scan equipment.

Explore Top AI Use Cases

Tags

AIMedicalAlzheimer'sDiagnosisMRIPETScansCustom AI ModelsCloudOn-device

Top Neuproscan Alternatives

User Reviews

Share your thoughts

If you've used this product, share your thoughts with other builders

Recent reviews

Frequently Asked Questions

What is NeuProScan?
NeuProScan is an AI platform designed to predict the likelihood of developing Alzheimer's disease years in advance using a single MRI scan.
Who can use NeuProScan?
NeuProScan can be used by individual doctors as well as large hospitals. It supports both on-device and cloud-based operations.
How does NeuProScan improve Alzheimer’s diagnosis?
NeuProScan improves Alzheimer’s diagnosis by selecting the most impactful MRI slices for analysis, which enhances diagnostic accuracy and optimizes the use of costly PET scans.
Is NeuProScan intended for medical diagnosis?
No, NeuProScan is provided for research purposes only and is not intended for medical diagnosis, treatment, or as a substitute for professional medical advice.
Can users create custom AI models with NeuProScan?
Yes, NeuProScan allows users to create their own custom AI models to tailor the analysis to specific needs.
What data does NeuProScan use for training its models?
NeuProScan uses the OASIS2 dataset for training its models and OASIS3 dataset for labeling the testing data.
How many MRI slices does NeuProScan use for prediction?
NeuProScan typically uses up to 9 selected MRI slices from different views (axial, coronal, and sagittal) for making a prediction.
What is the accuracy rate of NeuProScan’s predictions?
NeuProScan has successfully identified 88% of patients who were later diagnosed with Alzheimer’s as very likely to develop the disease.
What are the benefits of early Alzheimer’s detection with NeuProScan?
Early detection allows patients to plan for the future, manage legal and financial matters, and participate in clinical trials for new therapies.
What is the cost advantage of using MRI scans with NeuProScan over PET scans?
MRI scans are significantly cheaper than PET scans—$1300 compared to $5000—making them a cost-effective initial test for Alzheimer's eligibility.